The University of Chicago Header Logo

Connection

Ari Rosenberg to Thyroid Neoplasms

Back to Details
This is a "connection" page, showing publications Ari Rosenberg has written about Thyroid Neoplasms.
Ari Rosenberg
Connection Strength
0.619
Thyroid Neoplasms
  1. A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. Ann Oncol. 2023 08; 34(8):714-722.
    View in: PubMed
    Score: 0.619
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.